22 37 38 39 40 41 42 43 44 45 Among the non-fermenting Gram-negative bacteria, the Pseudomonas genus is the one with 46 the highest number of species [1, 2]. Pseudomonas aeruginosa, an opportunistic human 47 pathogen associated with an ever-widening array of life-threatening acute and chronic 48 infections, is the most clinically relevant species within this genus [3-5]. P. aeruginosa is one 49 of the CDC "ESKAPE" pathogens -Enterococcus faecium, Staphylococcus aureus, Klebsiella 50 pneumoniae, Acinetobacter baumannii, P. aeruginosa and Enterobacter species -, 51 emphasizing its impact on hospital infections and the ability of this microorganism to "escape" 52 the activity of antibacterial drugs [6]. P. aeruginosa can develop resistance to a wide range of 53 antibiotics due to a combination of intrinsic, adaptive, and acquired resistance mechanisms, 54 such as the reduction of its outer membrane permeability, over-expression of constitutive or 55 inducible efflux pumps, overproduction of AmpC cephalosporinase, and the acquisition of 56 antibiotic resistance genes (ARGs) through horizontal gene transfer (HGT) [4, 7, 8]. P. 57aeruginosa has a non-clonal population structure, punctuated by specific sequence types 58 (STs) that are globally disseminated and frequently linked to the dissemination of ARGs [4, 9]. 59 These STs have been designated as high-risk clones, of which major examples are ST111, 60 ST175, ST235 and ST244. 61